NA
PRPH

NewEdge Advisors’s ProPhase Labs PRPH Stock Holding History

NewEdge Advisors’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-23
Closed -$1.71K – 3604
2023
Q1 		$1.71K Sell
23
-141
-86% -$11.4K ﹤0.01% 3075
2022
Q4 		$13.6K Buy
+164
New +$17.7K ﹤0.01% 2266

Other funds holding PRPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AWE
Avidian Wealth Enterprises Houston, Texas $3.62B AUM 24.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return

NewEdge Advisors's PRPH Position: Q2 2023 in Review

NewEdge Advisors sold out of ProPhase Labs (PRPH) in Q2 2023, closing a stake of 23 shares — an estimated $1.71K sold.

NewEdge Advisors first reported a position in PRPH in Q4 2022 and held it in 2 quarters. The position peaked at $13.6K in Q4 2022. 45 funds tracked by Wall St. Rank hold PRPH as of Q2 2023.

  • NewEdge Advisors reported no remaining ProPhase Labs position as of Q2 2023 after selling out during the quarter.
  • NewEdge Advisors sold 23 ProPhase Labs shares in Q2 2023, an estimated $1.71K.
  • NewEdge Advisors first reported a position in ProPhase Labs in Q4 2022 and held it in 2 quarters.
  • NewEdge Advisors's ProPhase Labs position peaked at $13.6K in Q4 2022.
  • 45 funds tracked by Wall St. Rank held ProPhase Labs as of Q2 2023.

Based on NewEdge Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.